Page last updated: 2024-09-03

methylthio-adp and 4-chloromercuribenzenesulfonate

methylthio-adp has been researched along with 4-chloromercuribenzenesulfonate in 1 studies

Compound Research Comparison

Studies (methylthio-adp)	Trials (methylthio-adp)	Recent Studies (post-2010) (methylthio-adp)	Studies (4-chloromercuribenzenesulfonate)	Trials (4-chloromercuribenzenesulfonate)	Recent Studies (post-2010) (4-chloromercuribenzenesulfonate)
146	2	43	618	0	11

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Herbert, JM; Savi, P	1

Reviews

1 review(s) available for methylthio-adp and 4-chloromercuribenzenesulfonate

Article	Year
P2Y12, a new platelet ADP receptor, target of clopidogrel. Seminars in vascular medicine, 2003, Volume: 3, Issue:2 Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Down-Regulation; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine	2003

Article

Year

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Seminars in vascular medicine, 2003, Volume: 3, Issue:2

Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Down-Regulation; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine

2003